Reports for ATORVASTATIN
Ingredient
ATORVASTATIN
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CADUET | 80MG 5MG | TABLET | Resolved | 2024-08-06 | 2024-10-22 | 234685 |
| CADUET | 10MG 10MG | TABLET | Resolved | 2023-02-14 | 2023-03-20 | 184556 |
| CADUET | 10MG 10MG | TABLET | Avoided shortage | 2024-08-20 | 2024-08-27 | 235519 |
| CADUET | 5MG 10MG | TABLET | Resolved | 2018-04-09 | 2018-05-08 | 45233 |
| CADUET | 80MG 10MG | TABLET | Resolved | 2023-03-20 | 2024-08-27 | 187510 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2020-01-22 | 2020-04-22 | 103957 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2017-07-24 | 2017-08-04 | 16832 |
| JAMP ATORVASTATIN TABLETS | 40MG | TABLET | Resolved | 2023-02-06 | 2023-03-11 | 183651 |
| JAMP ATORVASTATIN TABLETS | 20MG | TABLET | Resolved | 2023-01-09 | 2023-02-03 | 180274 |
| LIPITOR | 80MG | TABLET | Resolved | 2023-05-05 | 2023-10-03 | 191722 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
| APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
| APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53291 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53294 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53324 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53321 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |